Recruiting

BoxX-NoAF

Sponsor:

AtriCure, Inc.

Code:

NCT06989775

Conditions

Post Operative Atrial Fibrillation

Atrial Fibrillation, Postoperative

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Accepted

Interventions

Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System

Study Details

Brief summary:

Post Operative Atrial Fibrillation (POAF) is the most common complication of cardiac surgery. POAF incidence can exceed 50% depending on the patient baseline characteristics and surgery type. Patients with POAF tend to have worse acute and long-term clinical outcomes. BoxX-NoAF is a randomized trial to evaluate if prophylactic ablation and exclusion of the Left Atrial Appendage at the time of other routine cardiac surgery can reduce the incidence of post operative AF and clinical AF during long term follow up in patients who have not yet developed AF but are at risk.

Conditions

Post Operative Atrial Fibrillation

Atrial Fibrillation, Postoperative

Study ID

NCT06989775

Start date

Oct 24, 2025

Status verified date

Jun, 2026

Completion date

Dec, 2029

Anticipated

Primary completion date

Feb, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Planned and clinically indicated for cardiac surgical procedure requiring cardiac bypass and opening of the pericardium
  • Age ≥ 65 years and CHA2DS2-VASc ≥ 3

Exclusion Criteria:

  • Documented history of atrial fibrillation or atrial flutter anytime prior to the cardiac surgery
  • Prior procedure involving opening the pericardium or entering the pericardial space
  • Patients undergoing off-pump surgery
  • Prior LAA occlusion, exclusion, or removal (surgical or percutaneous)
  • Presence of a permanent pacemaker
  • Infiltrative cardiomyopathies (i.e. amyloidosis)
  • Planned cardiac surgical procedure using non-sternotomy approaches
  • Patients whose planned procedure is a heart transplant or implantation of any long-term ventricular assist devices
  • Presence of ventricular arrhythmia
  • Active endocarditis
  • NYHA Class IV heart failure symptoms
  • Preoperative need for an intra-aortic ballon pump or intravenous inotropes
  • Active systemic infection at the time of cardiac surgery requiring antibiotics
  • Known allergy to Nitinol or nickel sensitivity
  • Known medical condition with expected survival of less than 1 year
  • Other comorbidities that in the Investigator's opinion make the subject unsuitable candidate to complete the protocol required intervention or visits
  • Current enrollment in an investigation or trial or an investigational devices or investigational drug that would interfere with this trial
  • Mental impairment or other psychiatric conditions which may not allow the patient to understand the nature, significance, and scope of the trial.
  • Pregnancy
  • Known severe symptomatic carotid disease

Study Design

Enrollment

960 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: Treatment

Index cardiac surgery + Ablation + Left Atrial Appendage Exclusion with AtriClip

no intervention: Control

Index cardiac surgery only

Interventions

Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System

Box lesion ablation with the Isolator Synergy EnCompass Clamp System and LAAE using the AtriClip LAA Exclusion System at the time of planned cardiac surgery

Primary outcome measure

  • Primary Effectiveness Endpoint [ Time Frame: 30 days post index cardiac surgical procedure ]
  • Primary Safety Endpoint [ Time Frame: 30 days post index cardiac surgical procedure ]

Central Contacts and Locations

Central contacts

Locations

St. Bernards Medical Center

Recruiting

Jonesboro, Arkansas, United States, 72401

Contacts

Principal Investigator:

Jay Bhama, MD

Sharp Memorial Hospital

Recruiting

San Diego, California, United States, 92123

Contacts

Principal Investigator:

Karl Limmer, MD

Morton Plant Hospital - BayCare Health System, Inc.

Recruiting

Clearwater, Florida, United States, 33759

Contacts

Principal Investigator:

John Ofenloch, MD

St. Joseph's Hospital - BayCare Health System, Inc.

Recruiting

Clearwater, Florida, United States, 33759

Contacts

Principal Investigator:

Andrew Sherman, MD

Orlando Health, Inc.

Recruiting

Orlando, Florida, United States, 32806

Contacts

Principal Investigator:

Anthony Rongione, MD

Sarasota Memorial Hospital

Recruiting

Sarasota, Florida, United States, 34239

Contacts

Principal Investigator:

Jeffrey E Sell, MD

Emory University

Recruiting

Atlanta, Georgia, United States, 30308

Contacts

Principal Investigator:

Jeffrey Miller, MD

Piedmont Hospital

Recruiting

Atlanta, Georgia, United States, 30309

Contacts

Principal Investigator:

Vinod Thourani, MD

Wellstar Health System

Recruiting

Marietta, Georgia, United States, 30062

Contacts

Principal Investigator:

Theresa Luu, MD

Northwestern Memorial Hospital

Recruiting

Chicago, Illinois, United States, 60611

Contacts

Principal Investigator:

Christopher Mehta, MD

Norton Healthcare

Recruiting

Louisville, Kentucky, United States, 40205

Contacts

Principal Investigator:

Steven Peterson, MD

MedStar Health Research Institute

Recruiting

Baltimore, Maryland, United States, 21218

Contacts

Principal Investigator:

Brian Bethea, MD

Corewell Health

Recruiting

Grand Rapids, Michigan, United States, 49503

Contacts

Principal Investigator:

Charles Willekes, MD

Trinity Health

Recruiting

Ypsilanti, Michigan, United States, 48197

Contacts

Principal Investigator:

Robert Lyons, MD

Mayo Clinic

Recruiting

Rochester, Minnesota, United States, 55905

Contacts

Principal Investigator:

Arman Arghami, M.D., M.P.H

Northwell Health

Recruiting

Manhasset, New York, United States, 11030

Contacts

Principal Investigator:

Alan Hartman, MD

Bethesda North Hospital

Recruiting

Cincinnati, Ohio, United States, 45242

Contacts

Principal Investigator:

Louis Albert Brunsting, MD

Cleveland Clinic Foundation

Recruiting

Cleveland, Ohio, United States, 44195

Contacts

Laurie Ann Moennich

moennil@ccf.org

Principal Investigator:

Edward Soltesz, MD

Allegheny-Singer Research Institute

Recruiting

Pittsburgh, Pennsylvania, United States, 15212

Contacts

Principal Investigator:

Stephen Bailey, MD

Ascension Saint Thomas

Recruiting

Nashville, Tennessee, United States, 37205

Contacts

Principal Investigator:

Amber Edwards, MD

Baylor Research Institute - Baylor Scott and White Research Institute

Recruiting

Dallas, Texas, United States, 75204

Contacts

Principal Investigator:

Kelley Hutcheson, MD

Charleston Area Medical Center

Recruiting

Charleston, West Virginia, United States, 25304

Contacts

Principal Investigator:

Hazaim Alwair, MD

Aspirus Hospital

Recruiting

Wausau, Wisconsin, United States, 54401

Contacts

Principal Investigator:

John Johnkoski, MD

Hamilton General Hospital

Recruiting

Hamilton, Ontario, Canada, L8L 2X2

Contacts

Principal Investigator:

Richard Whitlock, MD

London Health Sciences Centre, University Hospital

Recruiting

London, Ontario, Canada, N6A 5A5

Contacts

Principal Investigator:

Michael Chu, MD

Montreal Heart Institute

Recruiting

Montreal, Quebec, Canada, H1T 1C8

Contacts

Principal Investigator:

Denis Bouchard, MD

More Information

Sponsor

AtriCure, Inc.

Last update posted

Jun 29, 2026

Last verified

Jun, 2026

Keywords

  • Post operative AF
  • Clinical AF

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by AtriCure, Inc. on 2026-06-29.